Article Text

other Versions

Download PDFPDF
Effectiveness and cost-effectiveness of height screening programmes during the primary school years: a systematic review
  1. Debra A Fayter (daf5{at}
  1. University of York, United Kingdom
    1. John Nixon (jn105{at}
    1. University of York, United Kingdom
      1. Suzanne Hartley (s.hartley{at}
      1. University of Leeds, United Kingdom
        1. Amber Rithalia (ar518{at}
        1. University of York, United Kingdom
          1. Gary E Butler (g.e.butler{at}
          1. University of Reading, United Kingdom
            1. Mary Rudolf (mary.rudolf{at}
            1. University of Leeds, United Kingdom
              1. Paul Glasziou (paul.glasziou{at}
              1. University of Oxford, United Kingdom
                1. Martin Bland (mb55{at}
                1. University of York, United Kingdom
                  1. Lisa Stirk (ecm5{at}
                  1. University of York, United Kingdom
                    1. Marie E Westwood (mew3{at}
                    1. University of York, United Kingdom


                      Objective: To determine the effectiveness and cost-effectiveness of height screening (aged four to 11) to identify height-related conditions.

                      Design: Systematic review and economic modelling.

                      Setting and intervention: We included published and un-published studies of any design except case reports, conducted in any setting that measured children’s height as part of a population-level assessment. Studies were identified by electronic database searches, contact with experts and from bibliographies of retrieved studies.

                      Participants: Children aged between four and 11 years

                      Outcome measures: Diagnostic yield of height-related conditions and change in quality of life, as measured by Quality-adjusted Life Years (QALYs), for early versus late treatment of underlying conditions.

                      Results: Twelve studies described a height screening programme and provided data on the diagnostic yield of newly diagnosed height-related conditions. Where reported, yield for Growth Hormone Deficiency (per 1000 children screened) ranged from 0.05 (1/20,000) to 0.62 (approximately 1/1500) and for Turner syndrome (per 1000 children screened) was between 0.02 (1/50,000) and 0.07 (approximately 1/14,000). As a secondary gain, children with other potentially treatable conditions were identified; diagnostic yields ranged from 0.22 to 1.84 per 1000 children screened. Three studies did not detect any new cases, but all of these studies had methodological limitations. Economic modelling suggested that height screening is associated with health improvements and is cost effective for a willingness to pay threshold of £30,000 per QALY.

                      Conclusions: This review indicates the utility and acceptable cost-effectiveness of height screening arising from increased detection of height-related disorders and secondary pick-up of other undiagnosed conditions. However, further research is needed to obtain more reliable data on quality of life gains and costs associated with early interventions for height-related conditions. The exact role of height screening programmes in improving child health remains to be determined.

                      • child development
                      • growth
                      • mass screening
                      • systematic review

                      Statistics from

                      Request Permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                      Linked Articles

                      • Atoms
                        Howard Bauchner